JP5147866B2 - グルカン合成酵素阻害剤として有用であるピリダジノン誘導体 - Google Patents
グルカン合成酵素阻害剤として有用であるピリダジノン誘導体 Download PDFInfo
- Publication number
- JP5147866B2 JP5147866B2 JP2009553612A JP2009553612A JP5147866B2 JP 5147866 B2 JP5147866 B2 JP 5147866B2 JP 2009553612 A JP2009553612 A JP 2009553612A JP 2009553612 A JP2009553612 A JP 2009553612A JP 5147866 B2 JP5147866 B2 JP 5147866B2
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- alkenyl
- mmol
- aryl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 C*(c1ccccc1O1)C1=O Chemical compound C*(c1ccccc1O1)C1=O 0.000 description 55
- WGQKYBSKWIADBV-UHFFFAOYSA-N NCc1ccccc1 Chemical compound NCc1ccccc1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 3
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Nc1ccccc1 Chemical compound Nc1ccccc1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 3
- ZALVRXGHVSIOBK-MXNUEDNJSA-N CC1(CO/C(/C(Nc2cc(Cl)ccc2)=O)=C(/C=N)\N2CCNCC2)CC1 Chemical compound CC1(CO/C(/C(Nc2cc(Cl)ccc2)=O)=C(/C=N)\N2CCNCC2)CC1 ZALVRXGHVSIOBK-MXNUEDNJSA-N 0.000 description 2
- ZALVRXGHVSIOBK-UHFFFAOYSA-O CC1(COC(C(Nc2cc(Cl)ccc2)=O)=C(C=N)N2CC[NH2+]CC2)CC1 Chemical compound CC1(COC(C(Nc2cc(Cl)ccc2)=O)=C(C=N)N2CC[NH2+]CC2)CC1 ZALVRXGHVSIOBK-UHFFFAOYSA-O 0.000 description 2
- LAZFHIDCUUAVLK-UHFFFAOYSA-N O=S(Cc1ccccc1)=O Chemical compound O=S(Cc1ccccc1)=O LAZFHIDCUUAVLK-UHFFFAOYSA-N 0.000 description 2
- GNYHJZBXRGAKMY-BAXQROPYSA-O C/C(/C(Nc1cc(Cl)ccc1)=O)=C(/C=[NH2+])\N1CCNCC1 Chemical compound C/C(/C(Nc1cc(Cl)ccc1)=O)=C(/C=[NH2+])\N1CCNCC1 GNYHJZBXRGAKMY-BAXQROPYSA-O 0.000 description 1
- IJBKDFOIWRTMPS-JGWYZYIBSA-O C/C=C(\C(\Cl)=C(/C(N)=[NH2+])\N(CC1)CCN1S(Cc1ccccc1)(=O)=O)/N Chemical compound C/C=C(\C(\Cl)=C(/C(N)=[NH2+])\N(CC1)CCN1S(Cc1ccccc1)(=O)=O)/N IJBKDFOIWRTMPS-JGWYZYIBSA-O 0.000 description 1
- SSORGUDAILJFFQ-UHFFFAOYSA-N C/C=S\C(CC1)CCN1OC(c1ccccc1)=O Chemical compound C/C=S\C(CC1)CCN1OC(c1ccccc1)=O SSORGUDAILJFFQ-UHFFFAOYSA-N 0.000 description 1
- OHKYURRJKRNGSN-UHFFFAOYSA-N C/C=S\CCCCl Chemical compound C/C=S\CCCCl OHKYURRJKRNGSN-UHFFFAOYSA-N 0.000 description 1
- AQIAFTUPXQIBQF-UHFFFAOYSA-N C=CCCCCOC(C(N(c1cc(Cl)ccc1)N=C1)=O)=C1N(CC1)CCN1S(=O)=O Chemical compound C=CCCCCOC(C(N(c1cc(Cl)ccc1)N=C1)=O)=C1N(CC1)CCN1S(=O)=O AQIAFTUPXQIBQF-UHFFFAOYSA-N 0.000 description 1
- GECMFXNUBPGFDE-UHFFFAOYSA-N C=CCCCCOC(C(N(c1cc(Cl)ccc1)N=C1)=O)=C1N1CCNCC1 Chemical compound C=CCCCCOC(C(N(c1cc(Cl)ccc1)N=C1)=O)=C1N1CCNCC1 GECMFXNUBPGFDE-UHFFFAOYSA-N 0.000 description 1
- FLYWLIWXBMHJOE-UHFFFAOYSA-N C=CCCCCOC(C(N(c1cc(F)cc(F)c1)N=C1)=O)=C1N(CC1)CCN1S(Cc(cc1)ccc1N)(O)=O Chemical compound C=CCCCCOC(C(N(c1cc(F)cc(F)c1)N=C1)=O)=C1N(CC1)CCN1S(Cc(cc1)ccc1N)(O)=O FLYWLIWXBMHJOE-UHFFFAOYSA-N 0.000 description 1
- OTWWUYHRDYOIFW-UHFFFAOYSA-N C=[Br]Cc(cc1[N+]([O-])=O)ccc1Br Chemical compound C=[Br]Cc(cc1[N+]([O-])=O)ccc1Br OTWWUYHRDYOIFW-UHFFFAOYSA-N 0.000 description 1
- FTJVPPMWVRFOOB-UHFFFAOYSA-N CC(C(N(CC1)CCC1S(=O)=O)=C(C=O)OCC1(C)CC1)NNc1cc(C)ccc1 Chemical compound CC(C(N(CC1)CCC1S(=O)=O)=C(C=O)OCC1(C)CC1)NNc1cc(C)ccc1 FTJVPPMWVRFOOB-UHFFFAOYSA-N 0.000 description 1
- RYMZRCBTEHIEFX-UHFFFAOYSA-O CC(C(Nc1cc(F)cc(F)c1)=O)=C([NH3+])O Chemical compound CC(C(Nc1cc(F)cc(F)c1)=O)=C([NH3+])O RYMZRCBTEHIEFX-UHFFFAOYSA-O 0.000 description 1
- UGNLKIHDPKXDTF-UHFFFAOYSA-O CC(C([NH2+]CC1)N1C(C=N)=C(C(Nc1cc(F)cc(F)c1)=O)Cl)O Chemical compound CC(C([NH2+]CC1)N1C(C=N)=C(C(Nc1cc(F)cc(F)c1)=O)Cl)O UGNLKIHDPKXDTF-UHFFFAOYSA-O 0.000 description 1
- PIXYMWXVIPUKOV-LPYRZMQESA-N CC(C)(C)OC(N(CC1)CC(CO)N1/C(/C=N)=C(/C(Nc1cc(F)cc(F)c1)=O)\Cl)=O Chemical compound CC(C)(C)OC(N(CC1)CC(CO)N1/C(/C=N)=C(/C(Nc1cc(F)cc(F)c1)=O)\Cl)=O PIXYMWXVIPUKOV-LPYRZMQESA-N 0.000 description 1
- WFQCDRRQBTUNER-UHFFFAOYSA-O CC(C)(C)OC(N(CC1)CC2N1C(C=[NH2+])=C(C(Nc1cc(F)cc(F)c1)=O)OC2)=O Chemical compound CC(C)(C)OC(N(CC1)CC2N1C(C=[NH2+])=C(C(Nc1cc(F)cc(F)c1)=O)OC2)=O WFQCDRRQBTUNER-UHFFFAOYSA-O 0.000 description 1
- RDEKJOUVBCYZGN-XBQJKBNESA-N CC(C)(C)OC(N(CC1)CCN1C(C=NN(c1cc(Cl)ccc1)/C1=[O]\c2ccccc2)=C1/N=C(\C)/c1ccccc1)=O Chemical compound CC(C)(C)OC(N(CC1)CCN1C(C=NN(c1cc(Cl)ccc1)/C1=[O]\c2ccccc2)=C1/N=C(\C)/c1ccccc1)=O RDEKJOUVBCYZGN-XBQJKBNESA-N 0.000 description 1
- XXDLEHSJXNIGRA-MJEXAXSUSA-N CC(C)(C)OC(N(CC1)CN1/C(/C=N)=C(/C(Nc1cc(Cl)ccc1)=O)\Cl)=O Chemical compound CC(C)(C)OC(N(CC1)CN1/C(/C=N)=C(/C(Nc1cc(Cl)ccc1)=O)\Cl)=O XXDLEHSJXNIGRA-MJEXAXSUSA-N 0.000 description 1
- SUIBSJZGDLFENU-FTTSNFBXSA-N CC(C)(C)OC(N(CC1C=O)CN1/C(/C=N)=C(/C(Nc1cc(F)cc(F)c1)=O)\Cl)=O Chemical compound CC(C)(C)OC(N(CC1C=O)CN1/C(/C=N)=C(/C(Nc1cc(F)cc(F)c1)=O)\Cl)=O SUIBSJZGDLFENU-FTTSNFBXSA-N 0.000 description 1
- RNTUTAHZEGIJTD-UHFFFAOYSA-N CC(C)(C)OC(NCc(cc1OC)ccc1[N+]([O-])=O)=O Chemical compound CC(C)(C)OC(NCc(cc1OC)ccc1[N+]([O-])=O)=O RNTUTAHZEGIJTD-UHFFFAOYSA-N 0.000 description 1
- XITVDLJYDLMRBV-UHFFFAOYSA-N CC(C)S(N(CC1)CC(COS(C(C)C)(=O)=O)N1C(C=NN(c1cc(F)cc(F)c1)C1=O)=C1Cl)(=O)=O Chemical compound CC(C)S(N(CC1)CC(COS(C(C)C)(=O)=O)N1C(C=NN(c1cc(F)cc(F)c1)C1=O)=C1Cl)(=O)=O XITVDLJYDLMRBV-UHFFFAOYSA-N 0.000 description 1
- SWXDNCHJUGRIEZ-UHFFFAOYSA-O CC(C)SNCCN1C(C=[NH2+])=C(C(Nc2cc(F)cc(F)c2)=O)SCC1C Chemical compound CC(C)SNCCN1C(C=[NH2+])=C(C(Nc2cc(F)cc(F)c2)=O)SCC1C SWXDNCHJUGRIEZ-UHFFFAOYSA-O 0.000 description 1
- PMUPYMPBTYMXDU-UHFFFAOYSA-N CC(N(CCC1)C1O)=O Chemical compound CC(N(CCC1)C1O)=O PMUPYMPBTYMXDU-UHFFFAOYSA-N 0.000 description 1
- MOQXZTMVYSPKEI-UHFFFAOYSA-N CC(SCCCF)=O Chemical compound CC(SCCCF)=O MOQXZTMVYSPKEI-UHFFFAOYSA-N 0.000 description 1
- AFYLONXAUGVLCA-PYCFMQQDSA-O CC(c1ccccc1[SH2+])NCN/C(/C)=C(/C(Nc1ccccc1)=O)\OCC1(C)CC1 Chemical compound CC(c1ccccc1[SH2+])NCN/C(/C)=C(/C(Nc1ccccc1)=O)\OCC1(C)CC1 AFYLONXAUGVLCA-PYCFMQQDSA-O 0.000 description 1
- TUFYWQUQGBIXPC-RIGBCJBTSA-N CC1(CO/C(/C(Nc2cc(Cl)ccc2)=O)=C(/C=N)\N(CC2)CCN2/S=C/CNCc2cc(N)ncc2)CC1 Chemical compound CC1(CO/C(/C(Nc2cc(Cl)ccc2)=O)=C(/C=N)\N(CC2)CCN2/S=C/CNCc2cc(N)ncc2)CC1 TUFYWQUQGBIXPC-RIGBCJBTSA-N 0.000 description 1
- BPUSBOSXCIIMGU-YDTZLJHJSA-O CC1(CO/C(/C(Nc2cc(Cl)ccc2)=O)=C(/C=N)\N(CC2)CCN2/[S+]=C/CNCc(cc2)cc(OC)c2N)CC1 Chemical compound CC1(CO/C(/C(Nc2cc(Cl)ccc2)=O)=C(/C=N)\N(CC2)CCN2/[S+]=C/CNCc(cc2)cc(OC)c2N)CC1 BPUSBOSXCIIMGU-YDTZLJHJSA-O 0.000 description 1
- ZWAAOICZGNHAGF-MXNUEDNJSA-O CC1(CO/C(/C(Nc2cc(Cl)ccc2)=O)=C(/C=[NH2+])\N(CC2)CCN2S=O)CC1 Chemical compound CC1(CO/C(/C(Nc2cc(Cl)ccc2)=O)=C(/C=[NH2+])\N(CC2)CCN2S=O)CC1 ZWAAOICZGNHAGF-MXNUEDNJSA-O 0.000 description 1
- AXGOHHKODUBVRH-OQXAOINXSA-O CC1(CO/C(/C(Nc2cc(Cl)ccc2)O)=C(/C=N)\N(CC2)CCN2[SH+]CC(C2N=C(C)SC2C=C2)=C2N)CC1 Chemical compound CC1(CO/C(/C(Nc2cc(Cl)ccc2)O)=C(/C=N)\N(CC2)CCN2[SH+]CC(C2N=C(C)SC2C=C2)=C2N)CC1 AXGOHHKODUBVRH-OQXAOINXSA-O 0.000 description 1
- RPSQTMAHIIKLQR-DQRAZIAOSA-N CC1(CO/C(/C(Nc2ccccc2)=O)=C(/N)\NCCN(C)S(Cc2ccccc2)(O)=O)CC1 Chemical compound CC1(CO/C(/C(Nc2ccccc2)=O)=C(/N)\NCCN(C)S(Cc2ccccc2)(O)=O)CC1 RPSQTMAHIIKLQR-DQRAZIAOSA-N 0.000 description 1
- JPHHFANPYXBLOQ-UHFFFAOYSA-O CC1(COC(C(N(c2cc(Cl)ccc2)N=C2)=O)=C2N(CC2)CC[NH+]2S(Cc(cc2)ccc2NC(C)=O)(=O)=O)CC1 Chemical compound CC1(COC(C(N(c2cc(Cl)ccc2)N=C2)=O)=C2N(CC2)CC[NH+]2S(Cc(cc2)ccc2NC(C)=O)(=O)=O)CC1 JPHHFANPYXBLOQ-UHFFFAOYSA-O 0.000 description 1
- JNBARWONXQUEGF-UHFFFAOYSA-O CC1(COC(C(N(c2cccc(Cl)c2)N=C2)=O)=C2N2CC(c3c(CS(=O)=O)ccc(NC(C)=O)c3)[NH2+]CC2)CC1 Chemical compound CC1(COC(C(N(c2cccc(Cl)c2)N=C2)=O)=C2N2CC(c3c(CS(=O)=O)ccc(NC(C)=O)c3)[NH2+]CC2)CC1 JNBARWONXQUEGF-UHFFFAOYSA-O 0.000 description 1
- KRIQJNAPMAIDCA-UHFFFAOYSA-O CC1(COC(C(Nc2cc(Cl)ccc2)=O)=C(C=[NH2+])N(CC2)CCC2S(=O)=O)CC1 Chemical compound CC1(COC(C(Nc2cc(Cl)ccc2)=O)=C(C=[NH2+])N(CC2)CCC2S(=O)=O)CC1 KRIQJNAPMAIDCA-UHFFFAOYSA-O 0.000 description 1
- JWFTZPBMWFDFCC-UHFFFAOYSA-O CC1(COC(C([NH+](C2)c3cc(Cl)ccc3)=O)=C2N2CCNCC2)CC1 Chemical compound CC1(COC(C([NH+](C2)c3cc(Cl)ccc3)=O)=C2N2CCNCC2)CC1 JWFTZPBMWFDFCC-UHFFFAOYSA-O 0.000 description 1
- RDNXLNYPMXSJLT-BCNBWWNLSA-N CCC1(CO/C(/C=O)=C(/C=N\Nc2cc(F)cc(F)c2)\N2CCNCC2)CC1 Chemical compound CCC1(CO/C(/C=O)=C(/C=N\Nc2cc(F)cc(F)c2)\N2CCNCC2)CC1 RDNXLNYPMXSJLT-BCNBWWNLSA-N 0.000 description 1
- XEKMRDQCXHFWOK-UHFFFAOYSA-N CCC1(COC(C(N(c2cc(F)cc(F)c2)N=C2)=O)=C2N2CCNCC2)CC1 Chemical compound CCC1(COC(C(N(c2cc(F)cc(F)c2)N=C2)=O)=C2N2CCNCC2)CC1 XEKMRDQCXHFWOK-UHFFFAOYSA-N 0.000 description 1
- JFWPOMUUSVHUBU-UHFFFAOYSA-N CCCCCCCCOc(cccc1)c1N(C1=O)N=CC(N(CC2)CCN2C(OC(C)(C)C)=O)=C1Cl Chemical compound CCCCCCCCOc(cccc1)c1N(C1=O)N=CC(N(CC2)CCN2C(OC(C)(C)C)=O)=C1Cl JFWPOMUUSVHUBU-UHFFFAOYSA-N 0.000 description 1
- LUBFBCYOFNZSNJ-UHFFFAOYSA-O CCCCCCCCOc(cccc1)c1N(C1=O)N=CC(N2CC[NH2+]CC2)=C1Cl Chemical compound CCCCCCCCOc(cccc1)c1N(C1=O)N=CC(N2CC[NH2+]CC2)=C1Cl LUBFBCYOFNZSNJ-UHFFFAOYSA-O 0.000 description 1
- NVJMCAUYSBGLDO-UHFFFAOYSA-N CCN(CC(c1cccc(N)c1CS(=O)=O)N)C(C=N)=C(C(Nc1cc(F)cc(F)c1)=O)OC1CCCC1 Chemical compound CCN(CC(c1cccc(N)c1CS(=O)=O)N)C(C=N)=C(C(Nc1cc(F)cc(F)c1)=O)OC1CCCC1 NVJMCAUYSBGLDO-UHFFFAOYSA-N 0.000 description 1
- JNFFBAKYZOIJDC-ARMVOBGNSA-N CCN(CC)/C(/C=N)=C(/C(NC(CC(F)=C1)C=C1F)=O)\OCC1(C)CC1 Chemical compound CCN(CC)/C(/C=N)=C(/C(NC(CC(F)=C1)C=C1F)=O)\OCC1(C)CC1 JNFFBAKYZOIJDC-ARMVOBGNSA-N 0.000 description 1
- QHLBBOJCPXOTQG-NHCILGORSA-O CCN(CC1)CCN1/C(/C=[NH2+])=C(/C(Nc1cc(Cl)ccc1)=O)\Cl Chemical compound CCN(CC1)CCN1/C(/C=[NH2+])=C(/C(Nc1cc(Cl)ccc1)=O)\Cl QHLBBOJCPXOTQG-NHCILGORSA-O 0.000 description 1
- LRIRUQWLEVWGHR-UHFFFAOYSA-N CCN(CCNC(OC(C)(C)C)=O)C1=C(C2=O)OCCCCCOc(cccc3)c3N2N=C1 Chemical compound CCN(CCNC(OC(C)(C)C)=O)C1=C(C2=O)OCCCCCOc(cccc3)c3N2N=C1 LRIRUQWLEVWGHR-UHFFFAOYSA-N 0.000 description 1
- XPYRRYIWIRNFKT-UHFFFAOYSA-O CCN(CC[NH3+])C(C=N)=C(C(Nc1cc(F)cc(F)c1)=O)O Chemical compound CCN(CC[NH3+])C(C=N)=C(C(Nc1cc(F)cc(F)c1)=O)O XPYRRYIWIRNFKT-UHFFFAOYSA-O 0.000 description 1
- FLQXPEYAJYXKLX-UHFFFAOYSA-O CCN(CC[NH3+])C(C=NN1c(cc2)ccc2F)=C(CC=C)C1=O Chemical compound CCN(CC[NH3+])C(C=NN1c(cc2)ccc2F)=C(CC=C)C1=O FLQXPEYAJYXKLX-UHFFFAOYSA-O 0.000 description 1
- SOMLZCMYRCMFCV-KHPPLWFESA-N CCN(CN)/C(/N)=C(/C(Nc1cc(F)cc(F)c1)=O)\O Chemical compound CCN(CN)/C(/N)=C(/C(Nc1cc(F)cc(F)c1)=O)\O SOMLZCMYRCMFCV-KHPPLWFESA-N 0.000 description 1
- UBTBJJZAZBBOEL-PFONDFGASA-N CCN(CN)/C(/N)=C(/C(Nc1cc(F)cc(F)c1)=O)\OC1C(C)C1 Chemical compound CCN(CN)/C(/N)=C(/C(Nc1cc(F)cc(F)c1)=O)\OC1C(C)C1 UBTBJJZAZBBOEL-PFONDFGASA-N 0.000 description 1
- YTQWIKQKAWCHOZ-UHFFFAOYSA-N CCOCCOC(C(N(c1cc(C)ccc1)N=C1)=O)=C1N1CCNCC1 Chemical compound CCOCCOC(C(N(c1cc(C)ccc1)N=C1)=O)=C1N1CCNCC1 YTQWIKQKAWCHOZ-UHFFFAOYSA-N 0.000 description 1
- IHQGLXLAWGFEHV-UHFFFAOYSA-N CCOCCOC(C(N(c1cc(Cl)ccc1)N=C1)=O)=C1N1CCNCC1 Chemical compound CCOCCOC(C(N(c1cc(Cl)ccc1)N=C1)=O)=C1N1CCNCC1 IHQGLXLAWGFEHV-UHFFFAOYSA-N 0.000 description 1
- WIAKFKFKWHTULI-UHFFFAOYSA-O CCOCCOC(C(N(c1ccccc1)N=C1)S)=C1N(CC1)CC[NH+]1S(Cc1ccccc1)(=O)=O Chemical compound CCOCCOC(C(N(c1ccccc1)N=C1)S)=C1N(CC1)CC[NH+]1S(Cc1ccccc1)(=O)=O WIAKFKFKWHTULI-UHFFFAOYSA-O 0.000 description 1
- LLCGJRBSSJNKKJ-UHFFFAOYSA-O CCOCCOC(C(Nc1cc(Cl)ccc1)=O)=C(C=N)N1CC[NH2+]CC1 Chemical compound CCOCCOC(C(Nc1cc(Cl)ccc1)=O)=C(C=N)N1CC[NH2+]CC1 LLCGJRBSSJNKKJ-UHFFFAOYSA-O 0.000 description 1
- LRASDNCXDJEECT-UHFFFAOYSA-O CC[O](CC)CCOC(C(N(c1ccccc1)N=C1)=O)=C1N1CC[NH2+]CC1 Chemical compound CC[O](CC)CCOC(C(N(c1ccccc1)N=C1)=O)=C1N1CC[NH2+]CC1 LRASDNCXDJEECT-UHFFFAOYSA-O 0.000 description 1
- ACYIFHCSHILXEL-UHFFFAOYSA-N CC[O]1(CCOC(C(N(c2cc(Cl)ccc2)N=C2)=O)=C2N2CCN(Cc(c(Cl)ccc3)c3Cl)CC2)CC1 Chemical compound CC[O]1(CCOC(C(N(c2cc(Cl)ccc2)N=C2)=O)=C2N2CCN(Cc(c(Cl)ccc3)c3Cl)CC2)CC1 ACYIFHCSHILXEL-UHFFFAOYSA-N 0.000 description 1
- AFBPFSWMIHJQDM-UHFFFAOYSA-N CNc1ccccc1 Chemical compound CNc1ccccc1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 1
- MYKAZHUXAFBMQZ-UHFFFAOYSA-N COc1cc(CN)ccc1[N+]([O-])=O Chemical compound COc1cc(CN)ccc1[N+]([O-])=O MYKAZHUXAFBMQZ-UHFFFAOYSA-N 0.000 description 1
- IDPURXSQCKYKIJ-UHFFFAOYSA-N COc1ccc(CN)cc1 Chemical compound COc1ccc(CN)cc1 IDPURXSQCKYKIJ-UHFFFAOYSA-N 0.000 description 1
- YKXWHBKAYRYVHK-UHFFFAOYSA-O COc1cccc(N2N=CC(N3CC[NH2+]CC3)=C(c3cc(F)cc(F)c3)C2=O)c1 Chemical compound COc1cccc(N2N=CC(N3CC[NH2+]CC3)=C(c3cc(F)cc(F)c3)C2=O)c1 YKXWHBKAYRYVHK-UHFFFAOYSA-O 0.000 description 1
- IVSZLXZYQVIEFR-UHFFFAOYSA-N Cc1cccc(C)c1 Chemical compound Cc1cccc(C)c1 IVSZLXZYQVIEFR-UHFFFAOYSA-N 0.000 description 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Cc1ccccc1 Chemical compound Cc1ccccc1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 1
- YHYNFMGKZFOMAG-UHFFFAOYSA-N FC1CCCC1 Chemical compound FC1CCCC1 YHYNFMGKZFOMAG-UHFFFAOYSA-N 0.000 description 1
- UYEQWSPLEKFNBJ-VBWUQGJSSA-N N=C/C(/N1C(COCCCCC2CC2)CNCC1)=C\C(NC(C1C2)=CC(F)=CC12F)=O Chemical compound N=C/C(/N1C(COCCCCC2CC2)CNCC1)=C\C(NC(C1C2)=CC(F)=CC12F)=O UYEQWSPLEKFNBJ-VBWUQGJSSA-N 0.000 description 1
- ZKDYRBVVBRNKBK-VZUYPPRFSA-N N=C/C(/N1CCNCC1)=C(\C(Nc1cc(Cl)ccc1)=O)/OCCc1cccc(CCO)c1 Chemical compound N=C/C(/N1CCNCC1)=C(\C(Nc1cc(Cl)ccc1)=O)/OCCc1cccc(CCO)c1 ZKDYRBVVBRNKBK-VZUYPPRFSA-N 0.000 description 1
- NCGHUGRNZDIFNC-ACQATCRNSA-N N=C/C(/N1CCNCC1)=C(\C(Nc1ccccc1)=O)/OC1Cc2ccccc2CC1 Chemical compound N=C/C(/N1CCNCC1)=C(\C(Nc1ccccc1)=O)/OC1Cc2ccccc2CC1 NCGHUGRNZDIFNC-ACQATCRNSA-N 0.000 description 1
- NACSZMYRUJSCIT-SLZXQBSVSA-N N=C/C(/N1CCNCC1)=C(\C=O)/OC1CCCC1 Chemical compound N=C/C(/N1CCNCC1)=C(\C=O)/OC1CCCC1 NACSZMYRUJSCIT-SLZXQBSVSA-N 0.000 description 1
- SXVJREBMLLZDPT-UHFFFAOYSA-O N=CC(N1CC[NH2+]CC1)=C(C(Nc1cc(F)cc(F)c1)=O)O Chemical compound N=CC(N1CC[NH2+]CC1)=C(C(Nc1cc(F)cc(F)c1)=O)O SXVJREBMLLZDPT-UHFFFAOYSA-O 0.000 description 1
- WLHRCDWBJPPLRW-XGERBSIWSA-P NC/C=C/CCCCO/C(/C(Nc1cc(Cl)ccc1)=O)=C(/C=[NH2+])\N(CC1)CCN1S([OH2+])=O Chemical compound NC/C=C/CCCCO/C(/C(Nc1cc(Cl)ccc1)=O)=C(/C=[NH2+])\N(CC1)CCN1S([OH2+])=O WLHRCDWBJPPLRW-XGERBSIWSA-P 0.000 description 1
- ZJQUDTZLMLWNQU-UHFFFAOYSA-N NCC1C=CC(F)=CC1 Chemical compound NCC1C=CC(F)=CC1 ZJQUDTZLMLWNQU-UHFFFAOYSA-N 0.000 description 1
- BFWYZZPDZZGSLJ-UHFFFAOYSA-N NCc(cc1)ccc1N Chemical compound NCc(cc1)ccc1N BFWYZZPDZZGSLJ-UHFFFAOYSA-N 0.000 description 1
- XPARFBOWIYMLMY-UHFFFAOYSA-N NCc(cc1)cnc1Cl Chemical compound NCc(cc1)cnc1Cl XPARFBOWIYMLMY-UHFFFAOYSA-N 0.000 description 1
- YSXWSLITLDXLCG-UHFFFAOYSA-N NCc(cc1F)ccc1N Chemical compound NCc(cc1F)ccc1N YSXWSLITLDXLCG-UHFFFAOYSA-N 0.000 description 1
- AEUCNLPMBDBHOL-UHFFFAOYSA-N NCc(cc1O)ccc1N Chemical compound NCc(cc1O)ccc1N AEUCNLPMBDBHOL-UHFFFAOYSA-N 0.000 description 1
- ZDBWYUOUYNQZBM-UHFFFAOYSA-N NCc1cccc(N)c1 Chemical compound NCc1cccc(N)c1 ZDBWYUOUYNQZBM-UHFFFAOYSA-N 0.000 description 1
- FKOWIPKCHHSXLH-UHFFFAOYSA-O NN=CC(N1CC[NH2+]CC1)=C(C=O)c1cc(F)cc(F)c1 Chemical compound NN=CC(N1CC[NH2+]CC1)=C(C=O)c1cc(F)cc(F)c1 FKOWIPKCHHSXLH-UHFFFAOYSA-O 0.000 description 1
- IUQQUDOPPAGCQI-UHFFFAOYSA-N Nc(c(CS)ccc1)c1O Chemical compound Nc(c(CS)ccc1)c1O IUQQUDOPPAGCQI-UHFFFAOYSA-N 0.000 description 1
- PNPCRKVUWYDDST-UHFFFAOYSA-N Nc1cc(Cl)ccc1 Chemical compound Nc1cc(Cl)ccc1 PNPCRKVUWYDDST-UHFFFAOYSA-N 0.000 description 1
- KQOIBXZRCYFZSO-UHFFFAOYSA-N Nc1cc(F)cc(F)c1 Chemical compound Nc1cc(F)cc(F)c1 KQOIBXZRCYFZSO-UHFFFAOYSA-N 0.000 description 1
- LYZBWLKSLHDGLP-RIXMNKAPSA-N Nc1ccc(CS(N(CC2)CCN2/C(/C=N)=C(/C(Nc2cc(F)cc(F)c2)=O)\Cl)(O)=O)cc1 Chemical compound Nc1ccc(CS(N(CC2)CCN2/C(/C=N)=C(/C(Nc2cc(F)cc(F)c2)=O)\Cl)(O)=O)cc1 LYZBWLKSLHDGLP-RIXMNKAPSA-N 0.000 description 1
- HCSWZZZQVXSZMA-UHFFFAOYSA-O O=C1N(c(cc2)ccc2F)N=CC(N2CC[NH2+]CC2)=C1Br Chemical compound O=C1N(c(cc2)ccc2F)N=CC(N2CC[NH2+]CC2)=C1Br HCSWZZZQVXSZMA-UHFFFAOYSA-O 0.000 description 1
- VQHZUCIFWLYMID-UHFFFAOYSA-N O=C1N(c2cc(Cl)ccc2)N=CC(Cl)=C1Cl Chemical compound O=C1N(c2cc(Cl)ccc2)N=CC(Cl)=C1Cl VQHZUCIFWLYMID-UHFFFAOYSA-N 0.000 description 1
- PPSRNWJMQYCIBL-UHFFFAOYSA-N O=C1N(c2cc(Cl)ccc2)N=CC(N(CC2)Cc3c2nc(-c2ccccc2)[s]3)=C1Cl Chemical compound O=C1N(c2cc(Cl)ccc2)N=CC(N(CC2)Cc3c2nc(-c2ccccc2)[s]3)=C1Cl PPSRNWJMQYCIBL-UHFFFAOYSA-N 0.000 description 1
- XDWWSIQNSKTAEX-UHFFFAOYSA-N O=C1N(c2cc(Cl)ccc2)N=CC(N(CC2)Cc3c2nc(-c2ccccc2)[s]3)=C1OC1CCCC1 Chemical compound O=C1N(c2cc(Cl)ccc2)N=CC(N(CC2)Cc3c2nc(-c2ccccc2)[s]3)=C1OC1CCCC1 XDWWSIQNSKTAEX-UHFFFAOYSA-N 0.000 description 1
- HRFUXANQSXGEEG-UHFFFAOYSA-N O=C1N(c2cc(Cl)ccc2)N=CC(N2CCNCC2)=C1Cl Chemical compound O=C1N(c2cc(Cl)ccc2)N=CC(N2CCNCC2)=C1Cl HRFUXANQSXGEEG-UHFFFAOYSA-N 0.000 description 1
- JBTZVCNBJWWKFY-UHFFFAOYSA-N O=S(CCCOc1ccccc1)=O Chemical compound O=S(CCCOc1ccccc1)=O JBTZVCNBJWWKFY-UHFFFAOYSA-N 0.000 description 1
- ZXQRRAUATRRSFS-UHFFFAOYSA-N O=SC1CCNCC1 Chemical compound O=SC1CCNCC1 ZXQRRAUATRRSFS-UHFFFAOYSA-N 0.000 description 1
- DCFAFVFPTIYRJG-UHFFFAOYSA-N O=SCc(cc1)cc2c1nc[o]2 Chemical compound O=SCc(cc1)cc2c1nc[o]2 DCFAFVFPTIYRJG-UHFFFAOYSA-N 0.000 description 1
- XESOEBYBEJDNEQ-UHFFFAOYSA-O OC(C(N(c1cc(F)cc(F)c1)N=C1)=O)=C1N1CC[NH2+]CC1 Chemical compound OC(C(N(c1cc(F)cc(F)c1)N=C1)=O)=C1N1CC[NH2+]CC1 XESOEBYBEJDNEQ-UHFFFAOYSA-O 0.000 description 1
- PJMFGDYBTJEEDP-UHFFFAOYSA-N OCC1NCCN(Cc2ccccc2)C1 Chemical compound OCC1NCCN(Cc2ccccc2)C1 PJMFGDYBTJEEDP-UHFFFAOYSA-N 0.000 description 1
- PNPCRKVUWYDDST-UHFFFAOYSA-O [NH3+]c1cc(Cl)ccc1 Chemical compound [NH3+]c1cc(Cl)ccc1 PNPCRKVUWYDDST-UHFFFAOYSA-O 0.000 description 1
- IMLGJYRKLCMJPI-UHFFFAOYSA-N [O-][N+](c1cc(CO)ccc1O)=O Chemical compound [O-][N+](c1cc(CO)ccc1O)=O IMLGJYRKLCMJPI-UHFFFAOYSA-N 0.000 description 1
- OSTBLDHANBUNQO-UHFFFAOYSA-N [O-][N+](c1cc(CO)ccc1OCc1ccccc1)=O Chemical compound [O-][N+](c1cc(CO)ccc1OCc1ccccc1)=O OSTBLDHANBUNQO-UHFFFAOYSA-N 0.000 description 1
- JTBMRLWSORMKKA-UHFFFAOYSA-O [O-][N+](c1ccc(C[SH+]O)cc1)=O Chemical compound [O-][N+](c1ccc(C[SH+]O)cc1)=O JTBMRLWSORMKKA-UHFFFAOYSA-O 0.000 description 1
- OIMBYDFUXNAJSV-UHFFFAOYSA-O [SH2+]Cc(cc1)ccc1I Chemical compound [SH2+]Cc(cc1)ccc1I OIMBYDFUXNAJSV-UHFFFAOYSA-O 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91817107P | 2007-03-15 | 2007-03-15 | |
| US60/918,171 | 2007-03-15 | ||
| PCT/US2008/003257 WO2008115381A1 (en) | 2007-03-15 | 2008-03-12 | Pyridazinone derivatives useful as glucan synthase inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012230565A Division JP2013014622A (ja) | 2007-03-15 | 2012-10-18 | グルカン合成酵素阻害剤として有用であるピリダジノン誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010521461A JP2010521461A (ja) | 2010-06-24 |
| JP5147866B2 true JP5147866B2 (ja) | 2013-02-20 |
Family
ID=39525788
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009553612A Expired - Fee Related JP5147866B2 (ja) | 2007-03-15 | 2008-03-12 | グルカン合成酵素阻害剤として有用であるピリダジノン誘導体 |
| JP2012230565A Pending JP2013014622A (ja) | 2007-03-15 | 2012-10-18 | グルカン合成酵素阻害剤として有用であるピリダジノン誘導体 |
| JP2013259117A Pending JP2014051529A (ja) | 2007-03-15 | 2013-12-16 | グルカン合成酵素阻害剤として有用であるピリダジノン誘導体 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012230565A Pending JP2013014622A (ja) | 2007-03-15 | 2012-10-18 | グルカン合成酵素阻害剤として有用であるピリダジノン誘導体 |
| JP2013259117A Pending JP2014051529A (ja) | 2007-03-15 | 2013-12-16 | グルカン合成酵素阻害剤として有用であるピリダジノン誘導体 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8232274B2 (enExample) |
| EP (2) | EP2586778A3 (enExample) |
| JP (3) | JP5147866B2 (enExample) |
| KR (1) | KR20100049500A (enExample) |
| CN (1) | CN101730692A (enExample) |
| AR (1) | AR065721A1 (enExample) |
| AU (1) | AU2008227100B2 (enExample) |
| BR (1) | BRPI0809238A2 (enExample) |
| CA (1) | CA2680583A1 (enExample) |
| CL (1) | CL2008000725A1 (enExample) |
| CO (1) | CO6220966A2 (enExample) |
| EC (1) | ECSP099634A (enExample) |
| IL (1) | IL200906A0 (enExample) |
| MX (1) | MX2009009948A (enExample) |
| PE (1) | PE20081882A1 (enExample) |
| RU (1) | RU2009137946A (enExample) |
| TW (1) | TW200902516A (enExample) |
| WO (1) | WO2008115381A1 (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8536168B2 (en) | 2007-03-15 | 2013-09-17 | Novartis Ag | Benzyl and pyridinyl derivatives as modulators of the hedgehog signaling pathway |
| MX2009009849A (es) * | 2007-03-15 | 2009-09-24 | Schering Corp | Derivados de piridazinona sustituida con piperazina utiles como inhibidores de glucano sintasa. |
| ES2499018T3 (es) * | 2007-09-20 | 2014-09-26 | Irm Llc | Compuestos y composiciones como moduladores de la actividad de GPR119 |
| EP2296653B1 (en) | 2008-06-03 | 2016-01-27 | Intermune, Inc. | Compounds and methods for treating inflammatory and fibrotic disorders |
| US20100041663A1 (en) | 2008-07-18 | 2010-02-18 | Novartis Ag | Organic Compounds as Smo Inhibitors |
| US20120088769A1 (en) * | 2010-10-11 | 2012-04-12 | Axikin Pharmaceuticals, Inc. | Salts of arylsulfonamide ccr3 antagonists |
| FI20115234A0 (fi) | 2011-03-08 | 2011-03-08 | Biotie Therapies Corp | Uusia pyridatsinoni- ja pyridoniyhdisteitä |
| GB201111705D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Compounds and their use |
| GB201111704D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Novel compounds |
| JO3115B1 (ar) | 2011-08-22 | 2017-09-20 | Takeda Pharmaceuticals Co | مركبات بيريدازينون واستخدامها كمثبطات daao |
| AP2014007637A0 (en) | 2011-11-15 | 2014-05-31 | Takeda Pharmaceutical | Dihydroxy aromatic heterocyclic compound |
| WO2013155223A1 (en) * | 2012-04-10 | 2013-10-17 | The Regents Of The University Of California | Compositions and methods for treating cancer |
| AU2013203000B9 (en) | 2012-08-10 | 2017-02-02 | Lantheus Medical Imaging, Inc. | Compositions, methods, and systems for the synthesis and use of imaging agents |
| CN103664795B (zh) * | 2012-09-06 | 2017-10-03 | 华东理工大学 | 哒嗪酮类化合物及其用途 |
| AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
| CN104717924A (zh) | 2012-10-05 | 2015-06-17 | 皇家飞利浦有限公司 | 用于提供增强的x射线图像的医学成像系统及方法 |
| GB201222711D0 (en) * | 2012-12-17 | 2013-01-30 | Takeda Pharmaceutical | Novel compounds |
| US11039617B2 (en) | 2013-01-30 | 2021-06-22 | Agrofresh Inc. | Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness |
| US10070649B2 (en) | 2013-01-30 | 2018-09-11 | Agrofresh Inc. | Volatile applications against pathogens |
| WO2015031036A1 (en) * | 2013-08-26 | 2015-03-05 | Purdue Pharma L.P. | Azaspiro[4.5] decane derivatives and use thereof |
| RU2692485C2 (ru) | 2014-04-02 | 2019-06-25 | Интермьюн, Инк. | Противофиброзные пиридиноны |
| AU2015251501B2 (en) * | 2014-04-24 | 2019-08-15 | Hexima Limited | Agents and methods of treatment |
| WO2017155879A1 (en) | 2016-03-07 | 2017-09-14 | Agrofresh Inc. | Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops |
| EP3596043B1 (en) * | 2017-03-15 | 2025-12-03 | Lunella Biotech, Inc. | Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria, and pathogenic yeast |
| WO2018185013A1 (en) | 2017-04-03 | 2018-10-11 | Syngenta Participations Ag | Microbiocidal oxadiazole derivatives |
| US12435078B2 (en) | 2017-09-18 | 2025-10-07 | Gfb (Abc), Llc | Pyridazinones and methods of use thereof |
| CN109912476A (zh) * | 2019-03-27 | 2019-06-21 | 南通宝凯化工有限公司 | 一种异丙氨基磺酰氯的生产工艺 |
| CN112469713B (zh) * | 2019-06-21 | 2023-09-01 | 江苏豪森药业集团有限公司 | 芳基磷氧化物类衍生物抑制剂、其制备方法和应用 |
| WO2021113625A1 (en) * | 2019-12-06 | 2021-06-10 | Plexxikon Inc. | Compounds and methods for cd73 modulation and indications therefor |
| MX2022013615A (es) | 2020-04-30 | 2022-11-16 | Gilead Sciences Inc | Inhibidores de macrociclo de peptidilarginina deiminasas. |
| WO2023204124A1 (ja) * | 2022-04-20 | 2023-10-26 | 日本曹達株式会社 | ピリダジノン化合物並びに農園芸用殺菌剤、殺線虫剤、および医療用・動物用抗真菌剤 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS565734B2 (enExample) * | 1973-02-28 | 1981-02-06 | ||
| DE3048487A1 (de) * | 1980-12-22 | 1982-07-29 | Cassella Ag, 6000 Frankfurt | Basisch substituierte pyridazine, ihre herstellung und ihre verwendung |
| ES8601972A1 (es) | 1985-02-28 | 1985-11-16 | Abello Quimicos Farma Prod Sa | Procedimiento de obtencion de 1,2-diazin-3 (2h)-onas con interes farmaceutico |
| JPH04235975A (ja) * | 1991-01-21 | 1992-08-25 | Nissan Chem Ind Ltd | ピリダジノン誘導体および害虫防除剤 |
| GB2256587A (en) | 1991-06-11 | 1992-12-16 | American Cyanamid Co | Acetazolamide in sustained release form |
| HU227237B1 (en) * | 2001-09-27 | 2010-12-28 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | Substituted alkylpyridazinone derivatives, process for their preparation, pharmaceutical compositions containing them |
| CA2474850A1 (en) * | 2002-01-31 | 2003-08-07 | Daiichi Pharmaceutical Co., Ltd. | Imidazo[1,2-a]pyridine derivatives |
| DE10216144A1 (de) * | 2002-04-12 | 2003-11-06 | Bayer Ag | Substituierte 2-Phenyl-3(2H)-Pyridazinone |
| US20050209278A1 (en) * | 2002-04-25 | 2005-09-22 | Mcdonald Joseph J | Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| UA77526C2 (en) * | 2002-06-07 | 2006-12-15 | Sanofi Aventis | Substituted derivatives of 1-piperazineacylpiperidine, a method for the preparation thereof and their use in therapy |
| KR101190912B1 (ko) * | 2003-11-19 | 2012-10-12 | 어레이 바이오파마 인크. | Ｍｅｋ의 헤테로시클릭 억제제 및 그의 사용 방법 |
| WO2005117909A2 (en) * | 2004-04-23 | 2005-12-15 | Exelixis, Inc. | Kinase modulators and methods of use |
| GB0524991D0 (en) * | 2005-12-08 | 2006-01-18 | Ge Healthcare Ltd | Novel imaging agents for fibrosis |
| WO2007130383A2 (en) * | 2006-04-28 | 2007-11-15 | Northwestern University | Compositions and treatments using pyridazine compounds and secretases |
| MX2009009849A (es) * | 2007-03-15 | 2009-09-24 | Schering Corp | Derivados de piridazinona sustituida con piperazina utiles como inhibidores de glucano sintasa. |
-
2008
- 2008-03-12 JP JP2009553612A patent/JP5147866B2/ja not_active Expired - Fee Related
- 2008-03-12 BR BRPI0809238-9A patent/BRPI0809238A2/pt not_active IP Right Cessation
- 2008-03-12 EP EP12196756.6A patent/EP2586778A3/en not_active Withdrawn
- 2008-03-12 EP EP08726734.0A patent/EP2137179B1/en active Active
- 2008-03-12 CL CL2008000725A patent/CL2008000725A1/es unknown
- 2008-03-12 AU AU2008227100A patent/AU2008227100B2/en not_active Ceased
- 2008-03-12 US US12/046,755 patent/US8232274B2/en active Active
- 2008-03-12 MX MX2009009948A patent/MX2009009948A/es not_active Application Discontinuation
- 2008-03-12 CN CN200880016155A patent/CN101730692A/zh active Pending
- 2008-03-12 RU RU2009137946/04A patent/RU2009137946A/ru not_active Application Discontinuation
- 2008-03-12 PE PE2008000469A patent/PE20081882A1/es not_active Application Discontinuation
- 2008-03-12 WO PCT/US2008/003257 patent/WO2008115381A1/en not_active Ceased
- 2008-03-12 KR KR1020097021457A patent/KR20100049500A/ko not_active Withdrawn
- 2008-03-12 CA CA002680583A patent/CA2680583A1/en not_active Abandoned
- 2008-03-13 AR ARP080101033A patent/AR065721A1/es not_active Application Discontinuation
- 2008-03-13 TW TW097108919A patent/TW200902516A/zh unknown
-
2009
- 2009-09-13 IL IL200906A patent/IL200906A0/en unknown
- 2009-09-14 CO CO09098894A patent/CO6220966A2/es not_active Application Discontinuation
- 2009-09-14 EC EC2009009634A patent/ECSP099634A/es unknown
-
2012
- 2012-10-18 JP JP2012230565A patent/JP2013014622A/ja active Pending
-
2013
- 2013-12-16 JP JP2013259117A patent/JP2014051529A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20100049500A (ko) | 2010-05-12 |
| JP2014051529A (ja) | 2014-03-20 |
| PE20081882A1 (es) | 2008-12-27 |
| JP2010521461A (ja) | 2010-06-24 |
| US8232274B2 (en) | 2012-07-31 |
| CN101730692A (zh) | 2010-06-09 |
| BRPI0809238A2 (pt) | 2014-09-09 |
| US20090170861A1 (en) | 2009-07-02 |
| WO2008115381A1 (en) | 2008-09-25 |
| EP2586778A3 (en) | 2013-07-31 |
| JP2013014622A (ja) | 2013-01-24 |
| RU2009137946A (ru) | 2011-04-20 |
| IL200906A0 (en) | 2010-05-17 |
| AU2008227100A1 (en) | 2008-09-25 |
| CO6220966A2 (es) | 2010-11-19 |
| CL2008000725A1 (es) | 2008-11-14 |
| EP2137179B1 (en) | 2015-09-02 |
| MX2009009948A (es) | 2009-09-24 |
| AR065721A1 (es) | 2009-06-24 |
| AU2008227100B2 (en) | 2014-01-09 |
| CA2680583A1 (en) | 2008-09-25 |
| TW200902516A (en) | 2009-01-16 |
| EP2586778A2 (en) | 2013-05-01 |
| ECSP099634A (es) | 2009-10-30 |
| EP2137179A1 (en) | 2009-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014051529A (ja) | グルカン合成酵素阻害剤として有用であるピリダジノン誘導体 | |
| JP5241834B2 (ja) | プロテインキナーゼ阻害剤としての複素環アミド化合物 | |
| EP1942900B1 (en) | Use of pyrazolo [1,5-a] pyrimidine derivatives for inhibiting kinases methods for inhibiting protein kinases | |
| JP5031760B2 (ja) | プロテインキナーゼインヒビターとしてのイミダゾピラジン | |
| US8603998B2 (en) | Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors | |
| AU2014287471C1 (en) | Fused piperidine amides as modulators of ion channels | |
| US8022088B2 (en) | Substituted bicyclic and tricyclic thrombin receptor antagonists | |
| JP2009515882A (ja) | プロテインキナーゼを阻害するための方法 | |
| KR20100042287A (ko) | 항암요법으로서의 항-유사분열제 및 아우로라 키나제 억제제 조합물 | |
| US20070232635A1 (en) | Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists | |
| CN101321760A (zh) | 作为蛋白激酶抑制剂的吡唑并嘧啶 | |
| CN101516883A (zh) | 作为蛋白激酶抑制剂的咪唑并吡嗪化合物 | |
| CN101910164A (zh) | 作为蛋白质激酶抑制剂的二酰氨基噻唑衍生物 | |
| CN101910163A (zh) | 杂环脲和硫脲衍生物及其用法 | |
| AU2006302435B2 (en) | Use of pyrazolo [1 , 5 -a] pyrimidine derivatives for inhibiting protein kinases methods for inhibiting protein kinases | |
| US20090239890A1 (en) | Spiro substituted cyclopropane compounds for the treatment of inflammatory disorders | |
| HK1223611B (en) | Fused piperidine amides as modulators of ion channels |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101105 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120619 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120620 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120910 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120918 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121018 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20121113 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20121127 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20151207 Year of fee payment: 3 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| LAPS | Cancellation because of no payment of annual fees |